Vanguard Group
DARE icon

Vanguard Group’s Dare Bioscience DARE Stock Holding History

Vanguard Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.01M Buy
523,053
+128,156
+32% +$256K ﹤0.01% 3775
2025
Q3 		$829K Buy
394,897
+66,569
+20% +$150K ﹤0.01% 3836
2025
Q2 		$785K Hold
328,328
– – ﹤0.01% 3818
2025
Q1 		$949K Buy
328,328
+39,703
+14% +$123K ﹤0.01% 3725
2024
Q4 		$901K Buy
288,625
+900
+0.3% +$3.12K ﹤0.01% 3796
2024
Q3 		$932K Buy
287,725
+7,874
+3% +$26.9K ﹤0.01% 3794
2024
Q2 		$1.13M Sell
279,851
-7,676
-3% -$37.2K ﹤0.01% 3753
2024
Q1 		$1.69M Buy
287,527
+143
+0% +$701 ﹤0.01% 3645
2023
Q4 		$1.07M Buy
287,384
+328
+0.1% +$1.5K ﹤0.01% 3808
2023
Q3 		$1.59M Hold
287,056
– – ﹤0.01% 3668
2023
Q2 		$3.13M Sell
287,056
-1,296
-0.4% -$15.4K ﹤0.01% 3508
2023
Q1 		$3.6M Sell
288,352
-6,269
-2% -$83.2K ﹤0.01% 3458
2022
Q4 		$2.93M Buy
294,621
+157
+0.1% +$1.75K ﹤0.01% 3524
2022
Q3 		$3.53M Buy
294,464
+2,525
+0.9% +$34.7K ﹤0.01% 3502
2022
Q2 		$4.31M Buy
291,939
+4,187
+1% +$63K ﹤0.01% 3454
2022
Q1 		$5.14M Buy
287,752
+33,081
+13% +$625K ﹤0.01% 3515
2021
Q4 		$6.11M Buy
254,671
+74,145
+41% +$1.53M ﹤0.01% 3499
2021
Q3 		$3.62M Buy
180,526
+18,754
+12% +$370K ﹤0.01% 3831
2021
Q2 		$3.67M Buy
161,772
+43,826
+37% +$749K ﹤0.01% 3748
2021
Q1 		$2.39M Sell
117,946
-131,494
-53% -$3.21M ﹤0.01% 3827
2020
Q4 		$4.01M Buy
249,440
+179,700
+258% +$2.52M ﹤0.01% 3453
2020
Q3 		$836K Buy
69,740
+49,547
+245% +$661K ﹤0.01% 3697
2020
Q2 		$240K Buy
20,193
+11,057
+121% +$136K ﹤0.01% 3902
2020
Q1 		$93K Buy
9,136
+4,421
+94% +$59.5K ﹤0.01% 3952
2019
Q4 		$46K Hold
4,715
– – ﹤0.01% 4049
2019
Q3 		$43K Hold
4,715
– – ﹤0.01% 4093
2019
Q2 		$48K Buy
4,715
+833
+21% +$9.9K ﹤0.01% 4109
2019
Q1 		$65K Buy
3,882
+435
+13% +$5.06K ﹤0.01% 4043
2018
Q4 		$29K Sell
3,447
-1,390
-29% -$14.6K ﹤0.01% 4103
2018
Q3 		$57K Buy
4,837
+122
+3% +$1.64K ﹤0.01% 4116
2018
Q2 		$66K Sell
4,715
-1,397
-23% -$18.7K ﹤0.01% 4087
2018
Q1 		$61K Buy
6,112
+1,114
+22% +$22.5K ﹤0.01% 4061
2017
Q4 		$129K Buy
4,998
+70
+1% +$2.25K ﹤0.01% 3979
2017
Q3 		$185K Buy
4,928
+1,772
+56% +$86.9K ﹤0.01% 3936
2017
Q2 		$168K Sell
3,156
-4,339
-58% -$252K ﹤0.01% 3931
2017
Q1 		$731K Buy
7,495
+3,315
+79% +$478K ﹤0.01% 3663
2016
Q4 		$355K Sell
4,180
-457
-10% -$43.5K ﹤0.01% 3795
2016
Q3 		$568K Buy
4,637
+115
+3% +$25.8K ﹤0.01% 3734
2016
Q2 		$1.15M Buy
4,522
+1,377
+44% +$441K ﹤0.01% 3571
2016
Q1 		$1.02M Buy
3,145
+699
+29% +$197K ﹤0.01% 3593
2015
Q4 		$822K Buy
2,446
+488
+25% +$202K ﹤0.01% 3682
2015
Q3 		$861K Buy
1,958
+637
+48% +$320K ﹤0.01% 3678
2015
Q2 		$730K Buy
1,321
+1,006
+319% +$691K ﹤0.01% 3753
2015
Q1 		$340K Buy
315
+65
+26% +$62.9K ﹤0.01% 3915
2014
Q4 		$186K Buy
250
+37
+17% +$23.1K ﹤0.01% 3924
2014
Q3 		$108K Buy
+213
New +$113K ﹤0.01% 3948

Other funds holding DARE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group's DARE Position: Q4 2025 in Review

Vanguard Group increased its Dare Bioscience (DARE) stake by 32% in Q4 2025, buying an estimated $256K and bringing the position to 523,053 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3775.

Vanguard Group first reported a position in DARE in Q3 2014 and has held it in 46 quarters since. The position peaked at $6.11M in Q4 2021. 27 funds tracked by Wall St. Rank hold DARE as of Q4 2025.

  • Vanguard Group held 523,053 shares of Dare Bioscience worth $1.01M as of Q4 2025.
  • Vanguard Group bought 128,156 Dare Bioscience shares in Q4 2025, an estimated $256K.
  • Dare Bioscience made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3775 holding.
  • Vanguard Group first reported a position in Dare Bioscience in Q3 2014 and has held it in 46 quarters since.
  • Vanguard Group's Dare Bioscience position peaked at $6.11M in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.